🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the safety and tolerability of irinotecan liposome in combinat...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-04-08
Trial ID
NCT04796948
Treatments Being Tested
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
This is an open-label, multicenter, randomized, Phase 3 study in patients w...
Status
Completed
Location
Arizona Cancer Center
Start Date
2018-09-15
Trial ID
NCT03665441
Treatments Being Tested
This phase II trial compares the effect of sacituzumab govitecan and bevaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-10
Trial ID
NCT07504588
Multicenter open-label, phase II trial, to evaluate the efficacy and safety...
Status
Completed
Location
ICO
Start Date
2017-05-02
Trial ID
NCT03328884
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as liposome-encapsulated irinot...
Status
Terminated
Location
Hopital Saint Antoine
Start Date
2011-05
Trial ID
NCT01375816
Liposome Encapsulated SN38 (LE-SN38) is an oncology drug product consisting...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2002-10
Trial ID
NCT00046540
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as liposomal SN-38, work in dif...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00104754
Treatments Being Tested